TREATMENT OF ESSENTIAL THROMBOCYTHAEMIA BY ALPHA 2a INTERFERON
- 22 October 1988
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 332 (8617) , 960-961
- https://doi.org/10.1016/s0140-6736(88)92625-6
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Interferon alpha‐2b as treatment for Philadelphia‐negative chronic myeloproliferative disorders with excessive thrombocytosisBritish Journal of Haematology, 1989
- Low incidence of serum neutralizing factors in patients receiving recombinant alfa-2b interferon (intron a)The American Journal of Medicine, 1986